Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|April 16, 2016
Industry Perspective of Drug Development for Pregnant/Breastfeeding WomenJ M Korth-BradleyJournal of Intravenous Nursing : the Official Publication of the Intravenous Nurses Society|January 1, 1991
A pharmacokinetic primer for intravenous nursesJ M Korth-BradleyClinical Pharmacology and Therapeutics|July 10, 2016
Don't Do Different Things…Do Things Differently! Drug Development in Rare DiseasesM A Rudek, J M Korth-BradleyHaemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2016
Population pharmacokinetic modelling of factor IX activity after administration of recombinant factor IX in patients with haemophilia BA Suzuki, Y Tomono, J M Korth-BradleyPharmacotherapy|July 1, 1997
The influence of bromfenac on the pharmacokinetics and pharmacodynamic responses to glyburide in diabetic subjectsJ P Boni, W H Cevallos, S DeCleene, et al.Journal of Clinical Pharmacology|February 1, 1997
Evaluation of pharmacokinetic interaction between bromfenac and phenytoin in healthy malesK Gumbhir-Shah, W H Cevallos, S A DeCleene, et al.The Journal of Rheumatology|June 1, 1996
Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritisK Gumbhir-Shah, W H Cevallos, S A DeCleene, et al.Pharmacotherapy|October 17, 2001
Impact of age and gender on the pharmacokinetics of gemtuzumab ozogamicinJ M Korth-Bradley, J A Dowell, S P King, et al.The Annals of Pharmacotherapy|February 17, 2000
The pharmacokinetics of etanercept in healthy volunteersJ M Korth-Bradley, A S Rubin, R K Hanna, et al.The Annals of Pharmacotherapy|April 1, 1997
Absolute bioavailability of bromfenac in humansK Gumbhir-Shah, W H Cevallos, S A DeCleene, et al.Pageof 2